Edition:
India

NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

56.57USD
24 Nov 2017
Change (% chg)

$0.22 (+0.39%)
Prev Close
$56.35
Open
$56.34
Day's High
$56.84
Day's Low
$56.01
Volume
62,954
Avg. Vol
399,974
52-wk High
$81.48
52-wk Low
$49.25

Select another date:

Wed, Oct 25 2017

BRIEF-NuVasive Inc reports Q3 GAAP earnings per share $0.64

* NuVasive Inc sees ‍revenue​ and non-GAAP revenue of $1,030 million for fy 2017

BRIEF-NuVasive announces $100 million share repurchase program

* NuVasive Inc - ‍intends to fund repurchases under share repurchase program from cash on hand, cash generated from operations​

BRIEF-NuVasive receives expanded FDA 510(k) clearance For TLX Interbody System used in TLIF procedures

* NuVasive receives expanded FDA 510(k) clearance For TLX Interbody System used in TLIF procedures

BRIEF-NuVasive receives expanded FDA 510(k) clearance for innovative magnetic limb lengthening technology

* NuVasive receives expanded FDA 510(k) clearance for innovative magnetic limb lengthening technology

NuVasive sues former executive who moved to rival Alphatec

Oct 10 NuVasive Inc on Tuesday filed a lawsuit accusing a former executive and director of discouraging the company from buying rival medical device maker Alphatec Holdings Inc so he could invest in Alphatec himself, and ultimately become its executive chairman.

BRIEF-NuVasive files lawsuit against Patrick S. Miles

* Nuvasive files lawsuit against patrick s. Miles to protect corporate assets and stakeholders' interests

BRIEF-NuVasive says ‍commercial launch of its lessray software technology system​

* Nuvasive Inc - ‍commercial launch of its Lessray Software technology system​ Source text for Eikon: Further company coverage:

BRIEF-Nuvasive buys privately-held medical device co Vertera Spine

* ‍Announced acquisition of Vertera Spine, a privately-held medical device company​

BRIEF-Nuvasive receives FDA 510(K) clearance for leading EOS innovation

* Nuvasive receives FDA 510(K) clearance for leading EOS innovation Source text for Eikon: Further company coverage:

BRIEF-NuVasive appoints Rajesh Asarpota as CFO

* NuVasive appoints Rajesh Asarpota as chief financial officer, effective September 1, 2017 Source text for Eikon: Further company coverage:

Select another date: